4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-25-002708
Chief Financial Officer sold 74,773 shares at $0.45 ($33,947)
- Chief Financial Officer acquired 74,773 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mostafa Adam S. Chief Financial Officer | 2025-01-23 | Grant or award | +74,773 | 74,773 | D | ||
| Mostafa Adam S. Chief Financial Officer | 2025-01-24 | Sale | −74,773 | $0.45 | $33,947 | 0 | D |
| Open-market sales · 74,773 sh · avg $0.45 · $33,947 | |||||||
Loading xslF345X05/wk-form4_1738019736.xml…